drugset / Trial / NCT04171349

Articaine vs Dexmedetomidine Supplemented Articaine

NCT04171349 ↗

Phase 0 Completed 50 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study to test efficacy of adding dexmedetomidine to articaine on sensory, motor and duration of analgesia during hemodialysis fistula creation under ultrasound guided supraclavicular block

Timeline

Start
2019-06-01
Primary completion
2019-10-01
Completion
2019-11-01

Outcome

Met primary endpoint

paper Longer sensory block duration was in Group AD (230-260 min) than in Group A (172-185 min) with P < 0.001. PMID 33487824 ↗

paper In addition, motor block duration was significantly longer in Group AD than in Group A PMID 33487824 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Articaine Other / unclassified 2 % Other
Subject Articaine Other / unclassified 40 ml Other
Subject Dexmedetomidine Other / unclassified 1 ug/kg Other

Indications